Sumoson, Riza H.
HRN: 04-91-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2024
CEFUROXIME 1.5GM (VIAL)
07/03/2024
07/03/2024
IV
1.5
Q8 For Three Doses
CIPTL TC UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes